Single Source for Continuation of the Accelerating Medicines Partnership (AMP) in Common Metabolic Diseases (CMD) Knowledge Portal (U01 Research Project (Cooperative Agreement) Clinical Trial not allowed)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering a non-competitive funding opportunity titled "Single Source for Continuation of the Accelerating Medicines Partnership (AMP) in Common Metabolic Diseases (CMD) Knowledge Portal," aimed exclusively at the Broad Institute, Inc. This cooperative agreement will provide $15 million over five years to support the ongoing development and maintenance of the AMP CMD Knowledge Portal, which serves as a critical resource for understanding biological heterogeneity in patients with common metabolic diseases and their complications. The initiative is part of a collaborative effort involving the NIH, pharmaceutical companies, and nonprofit organizations to enhance data integration, analytical tools, and user accessibility, ultimately striving for sustainability. Applications are due by March 6, 2026, and will be peer-reviewed, with funding awarded only to meritorious submissions. For further inquiries, interested parties can contact the Division of Diabetes, Endocrinology and Metabolic Diseases at NIDDK_DEM@nih.gov.
Eligible Applicants
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Only the following applicant is eligible to apply for this single source funding: The Broad Institute, Inc. Please refer to Section I. Notice of Funding Opportunity Information for more details.